Loading...
Projects / Programmes
A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases
Research activity
| Code | Science | Field | Subfield |
|---|---|---|---|
| 1.09.00 | Natural sciences and mathematics | Pharmacy |
| Code | Science | Field |
|---|---|---|
| 3.01 | Medical and Health Sciences | Basic medicine |
Evaluation
(metodology)
Points
4,256.52
A''
959.38
A'
2,569.72
A1/2
3,314.3
CI10
6,618
CImax
173
h10
42
A1
15.91
A3
0.29
Data for the last 5 years (citations for the last 10 years) on
February 6, 2026;
Data for score A3 calculation refer to period
2020-2024
Data for ARIS tenders (
04.04.2019 – Programme tender,
archive
)
Citations
Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
| Database | Linked records | Citations | Pure citations | Average pure citations |
|---|---|---|---|---|
| WoS | 338 | 7,718 | 6,471 | 19.14 |
| Scopus | 344 | 8,365 | 7,014 | 20.39 |
Organisations (1) , Researchers (6)
0787 University of Ljubljana, Faculty of Pharmacy
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 53656 | Pharmacy | Researcher | 2024 - 2026 | 42 | |
| 2. | 32034 | Oncology | Researcher | 2024 - 2026 | 229 | |
| 3. | 36438 | Pharmacy | Researcher | 2024 - 2026 | 278 | |
| 4. | 30816 | Pharmacy | Head | 2024 - 2026 | 300 | |
| 5. | 52378 | Pharmacy | Researcher | 2024 - 2026 | 45 | |
| 6. | 28334 | Pharmacy | Researcher | 2024 - 2026 | 453 |